• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Kronos Bio Inc (NQ: KRON )

    0.8500 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Kronos Bio Inc

    < Previous 1 2 3 4 Next >
    5 Most Expensive Health Care Stocks You Should Worry About
    The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
    Via Benzinga
    Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash. 
    Via Benzinga
    Kronos Bio Announces Discovery Collaboration with Genentech to Advance Novel Therapies Against Transcriptional Targets in Oncology
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Expert Ratings for Kronos Bio
    Via Benzinga
    Kronos Bio Starts Dosing In Early-Stage Leukemia Study With Next-Gen SYK Inhibitor
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
      OnFriday, 143 stocks hit new 52-week lows. 
    Via Benzinga
    The Week In Charts: Millon-Dollar Trade Missed?
    Recent big winners and how we picked them, nuances of trend trading, and answering your questions. 
    Via Talk Markets
    Kronos Bio Presents Preclinical Data Supporting Anti-Leukemic Activity of Lanraplenib in Combination with Multiple Targeted Agents in Acute Myeloid Leukemia (AML) Preclinical Models at American Society of Hematology Meeting
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Announces Selection of Recommended Phase 2 Dose for its Oral CDK9 Inhibitor, KB-0742, After Reaching Target Engagement Goal with Acceptable Safety Profile in Ongoing Phase 1/2 Clinical Trial
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Announces Participation in Upcoming Investor Conferences
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Recap: Kronos Bio Q4 Earnings
    Kronos Bio (NASDAQ:KRON) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement.... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
      During Wednesday's session, 107 stocks hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
      On Monday, 79 companies reached new 52-week lows. 
    Via Benzinga
    Palo Alto To Surge Around 38%? Plus This Analyst Predicts $65 For Helmerich & Payne
    Barclays raised the price target on Palo Alto Networks, Inc. (NASDAQ: PANW) from $200 to $215. Barclays analyst Saket Kalia maintained an Overweight rating on the stock. Palo Alto Networks shares fell... 
    Via Benzinga
    Kronos Bio Reports Recent Business Progress and Third-Quarter 2022 Financial Results
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Announces Prioritization of Clinical Portfolio to Focus on Lanraplenib and KB-0742
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio to Present Preclinical Data for KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers, in Pediatric Cancer Models in Poster Presentation at EORTC-NCI-AACR 2022
    Company Plans to Provide Update and Recommended Phase 2 Dose from Ongoing KB-0742 Phase 1/2 Clinical Trial in Q4 2022 
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
    Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low... 
    Via Benzinga
    Recap Of Monday's Biotech Catalysts - End Of the Day Summary
    Via Benzinga
    Kronos Bio Shares Fall After Initial-Stage Blood Cancer Study Takes-off
    Kronos Bio (NASDAQ: KRON) has initiated patient dosing in a Phase 1b/2 clinical trial of lanraplenib in combination with gilteritinib in patients with relapsed/refractory FLT3-mutated acute myeloid... 
    Via Benzinga
    The Week In Charts: The Trading Secret That's Really Not A Secret
    Discussing the secret that's not, really; also recent winners, dealing with open profit drawdowns and more. 
    Via Talk Markets
    12 Health Care Stocks Moving In Thursday's Intraday Session
      
    Via Benzinga
    7 Nasdaq Stocks to Buy on the Dip
    If you want to maximize your return potential and can handle some heat, here are compelling Nasdaq stocks to buy on the dip. 
    Via InvestorPlace
    38 Stocks Moving In Friday's Mid-Day Session
    Gainers Leju Holdings Limited (NYSE: LEJU) surged 27.8% to $4.0413. 
    Via Benzinga
    66 Biggest Movers From Friday
    Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year. 
    Via Benzinga
    20 Stocks Moving in Friday's Pre-Market Session
    Gainers Exicure, Inc. (NASDAQ: XCUR) shares rose 28.1% to $0.1550 in pre-market trading. Exicure said in Form4 filing a director bought 1,472,126 shares at average price of $0.19 per share. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    On Thursday, 236 companies hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    During Wednesday's session, 18 companies made new 52-week lows. Noteable 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) is the largest company in terms of market... 
    Via Benzinga
    50 Biggest Movers From Yesterday
    Gainers electroCore, Inc. (NASDAQ: ECOR) shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for... 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.